Cgt

CELL AND GENE THERAPY

SCALE YOUR CELL AND GENE THERAPY WITH THE STEMEXPRESS SUPPLY CHAIN

OVERVIEW

As the market for cell and gene therapies continues to expand, manufacturers and hospitals need help navigating the supply chain, from R&D to point-of-care.

Below are the three most significant issues we’ve identified when facilitating the relationship between the cell and gene therapy manufacturer and the hospital’s point-of-care.

01. Scale

Cell and gene therapy developers struggle with the ability to rapidly commercialize their new therapies to health care providers.

02. Access

Hospitals need a partner to provide consistent access to innovative CGT therapies for patients throughout their entire network of hospitals and clinics.

03. Execution

Hospitals and CGT manufacturers lack consistent point-of-care assistance matched with the logistics of storing and distributing CGT products.

POINT-OF-CARE PROCESS

FROM LEUKAPHERESIS TO POST-INFUSION

StemExpress Cell and Gene Therapy Partnerships for Hospitals and Cell and Gene Therapy Manufacturers

Hi, have questions?

A StemExpress Expert is happy to help!

Got a Question?

Read our FAQs to answer your questions regarding the different types of donations, donor requirements, and our donation process.

READ OUR FAQS